US Patent

US9474746 — Methods for stabilizing oxidatively unstable compositions

Formulation · Assigned to Johnson and Johnson Vision Care Inc · Expires 2028-03-27 · 2y remaining

Vulnerability score 63/100 Moderate — design-around opportunities exist

What this patent protects

This patent discloses methods for stabilizing ophthalmic compositions, specifically those that are oxidatively unstable.

USPTO Abstract

Ophthalmic compositions and methods of preparing such compositions are disclosed.

Drugs covered by this patent

ketotifen-fumarate (KETOTIFEN FUMARATE)

Patent Metadata

Patent number: US9474746
Jurisdiction: US
Classification: Formulation
Expires: 2028-03-27
Drug substance claim: No
Drug product claim: Yes
Assignee: Johnson and Johnson Vision Care Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.